• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Effect on low-molecular-weight heparin obtained using a chitinolytic complex on the anticoagulant activity of plasma in rabbits and rats].

作者信息

Drozd N N, Tolstenkov A S, Makarov V A, Miftakhova N T, Bannikova G E, Sukhanova P P, Varlamov V P, Vikhoreva G E

出版信息

Eksp Klin Farmakol. 2007 Mar-Apr;70(2):40-4.

PMID:17523450
Abstract

The anticoagulant activity of low-molecular-weight heparin with an average molecular weight of 4.7 kD (LMWH-4.7) has been studied. This derivative was prepared from unfractionated heparin with the help of chitinolytic enzyme complex from Streptomyces kurssanovii. The antithrombin activity of LMWH-4.7 (aIla activity) was 72 +/- 9 IU/mg and the activity with respect to the blood coagulation factor Xa (aXa activity) was 200 +/- 33 IU/mg, which corresponded to an aXa/aIIa ratio of 2.8 (necessary for effective antithrombotic drugs). The aIIa and aXa activity exhibited a dose-dependent variation upon intravenous and subcutaneous injections in rabbits, so that a high aIIa/aXa ratio was retained: 5 min after the intravenous injection of a minimum dose (0.3 mg/kg), this ratio was 2, 7, and for a greater dose (3.0 mg/kg) it reached 3.8. Subcutaneous injections were followed by slow elimination of the anticoagulant within 24 h. LMWH-4.7 upon intraperitoneal injections produced a dose-dependent inhibition of a model thrombosis in rats. Complete inhibition was observed for a dose of 3 mg/kg. Thus, it is possible to obtain active LMW heparin with the help of chitinases.

摘要

相似文献

1
[Effect on low-molecular-weight heparin obtained using a chitinolytic complex on the anticoagulant activity of plasma in rabbits and rats].
Eksp Klin Farmakol. 2007 Mar-Apr;70(2):40-4.
2
[Anticoagulant activity of low-molecular-weight heparins obtained using a hydrolase complex].[使用水解酶复合物获得的低分子量肝素的抗凝血活性]
Eksp Klin Farmakol. 2007 Nov-Dec;70(6):19-24.
3
Anticoagulant pharmacodynamics of tinzaparin following 175 iu/kg subcutaneous administration to healthy volunteers.健康志愿者皮下注射175 iu/kg替扎肝素后的抗凝药效学。
Thromb Res. 2001 Feb 15;101(4):243-54. doi: 10.1016/s0049-3848(00)00412-6.
4
Comparative pharmacokinetics of LMWHs.低分子肝素的比较药代动力学。
Semin Thromb Hemost. 2000;26 Suppl 1:31-8. doi: 10.1055/s-2000-9497.
5
M118--a rationally engineered low-molecular-weight heparin designed specifically for the treatment of acute coronary syndromes.M118——一种经过合理设计的低分子量肝素,专门用于治疗急性冠脉综合征。
Thromb Haemost. 2009 Nov;102(5):900-6. doi: 10.1160/TH09-02-0105.
6
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.肝素和低分子量肝素在治疗深静脉血栓形成中的剂量、抗凝及抗血栓作用
Semin Thromb Hemost. 1997;23(1):83-90. doi: 10.1055/s-2007-996074.
7
Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.吸入性低分子量肝素克赛在健康受试者中的抗凝作用。
J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):603-14.
8
Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination.单次皮下注射低剂量肝素或低分子量肝素 - 双氢麦角胺组合后的纤溶和抗凝活性。
Thromb Haemost. 1988 Jun 16;59(3):388-91.
9
Evaluation of the biological effects of low-molecular-weight heparins.低分子量肝素的生物学效应评估。
Haemostasis. 1988;18 Suppl 3:23-32. doi: 10.1159/000215865.
10
Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.低分子量肝素及其寡糖组分的鱼精蛋白中和。
Anal Bioanal Chem. 2011 Jan;399(2):763-71. doi: 10.1007/s00216-010-4220-8. Epub 2010 Oct 5.